Muken Ross 4

What Happened

• Muken Ross, President of SOPHiA GENETICS SA (SOPH), sold a total of 4,736 shares in two open-market transactions to satisfy tax-withholding obligations tied to recent RSU vesting. On 2026-04-08 he sold 2,786 shares at a weighted average price of $4.84 for proceeds of $13,488; on 2026-04-09 he sold 1,950 shares at a weighted average price of $4.74 for proceeds of $9,239. Total proceeds were approximately $22,727. These sales were effected under a pre-established Rule 10b5-1 trading plan and were not discretionary.

Key Details

• Transaction dates and reported weighted-average prices:
  • 2026-04-08: 2,786 shares sold; weighted avg price $4.84; proceeds $13,488 (price range reported: $4.77–$4.95).
  • 2026-04-09: 1,950 shares sold; weighted avg price $4.74; proceeds $9,239 (price range reported: $4.665–$4.85).
• Reason: Shares sold to satisfy tax withholding from restricted stock units that vested April 2–3, 2026 (footnote F1).
• Trading plan: Sales executed pursuant to a pre-established Rule 10b5-1 plan (non-discretionary) (F1).
• Price detail disclosure: Weighted-average prices reported; the filer can provide the number of shares sold at each separate price within the ranges on request (F2, F3).
• Filing: Report filed 2026-04-10 (covers transactions on 2026-04-08 and 2026-04-09); appears timely based on Form 4 rules.
• Shares owned after the transactions: Not specified in the provided excerpt.

Context

• These sales were tax-withholding related and executed under a 10b5-1 plan, which generally indicates routine, pre-planned transactions rather than discretionary insider selling. Such transactions are common following RSU vesting and do not necessarily signal the insider's view of the company's prospects.